1 – 6 of 6
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
(
- Contribution to journal › Article
- 2011
-
Mark
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
(
- Contribution to journal › Article
- 2009
-
Mark
No Risk of Maternal EBV Infection for Childhood Leukemia.
2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2790-2792(
- Contribution to journal › Article
- 2008
-
Mark
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
(
- Contribution to journal › Article
- 2007
-
Mark
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
(
- Contribution to journal › Article
- 2003
-
Mark
Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring.
(
- Contribution to journal › Article